CyFRASS-TR: A practical clinical predictive model for acute irinotecan-induced toxicity to enhance patient safety in solid tumor management
Journal of Oncology Pharmacy Practice
Published online on April 13, 2026
Abstract
Journal of Oncology Pharmacy Practice, Ahead of Print.
Irinotecan-based chemotherapy regimens are mainstay treatments for various solid tumors but are frequently complicated by acute toxicities that can impair treatment adherence and clinical outcomes. Personalized risk prediction is essential to optimize ...
Irinotecan-based chemotherapy regimens are mainstay treatments for various solid tumors but are frequently complicated by acute toxicities that can impair treatment adherence and clinical outcomes. Personalized risk prediction is essential to optimize ...